Immix Biopharma, Inc.
NASDAQ:IMMX
1.58 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 23.975 | 29.319 | 17.51 | 19.582 | 12.654 | 11.463 | 13.437 | 16.917 | 18.402 | 19.061 | 17.644 | 0.038 | 0.111 | -0.391 | 0.391 | -0.734 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.782 | 0 | 1.468 |
Cash and Short Term Investments
| 23.975 | 29.319 | 17.51 | 19.582 | 12.654 | 11.463 | 13.437 | 16.917 | 18.402 | 19.061 | 17.644 | 0.038 | 0.111 | 0.391 | 0.391 | 0.734 |
Net Receivables
| 1.98 | 2.025 | 1.172 | 0.652 | 0.297 | 0.322 | 0.256 | 0.182 | 0.165 | 0.064 | 0.026 | 0.189 | 0.174 | 0 | 0.127 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.026 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 1.375 | 1.571 | 1.106 | 2.097 | 2.557 | 1.248 | 1.205 | 0.292 | 0.516 | 0.888 | 0.516 | 0.016 | 0.007 | 0 | 0.014 | 0 |
Total Current Assets
| 27.331 | 32.915 | 19.788 | 22.332 | 15.507 | 13.033 | 14.898 | 17.391 | 19.083 | 20.012 | 18.186 | 0.243 | 0.292 | 0.391 | 0.532 | 0.734 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 1.485 | 1.412 | 0.05 | 0.04 | 0.003 | 0.003 | 0.004 | 0.004 | 0.005 | 0.005 | 0.006 | 0.006 | 0.007 | 0 | 0.007 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.02 | 0.02 | 0.087 | 0.103 | 0.057 | 0.175 | 0.007 | 0 | 0 | 0 | 0 | 0.246 | 0.053 | -0.391 | 0 | -0.734 |
Total Non-Current Assets
| 1.505 | 1.432 | 0.137 | 0.143 | 0.059 | 0.178 | 0.01 | 0.004 | 0.005 | 0.005 | 0.006 | 0.252 | 0.06 | -0.391 | 0.007 | -0.734 |
Total Assets
| 28.836 | 34.348 | 19.925 | 22.475 | 15.566 | 13.211 | 14.908 | 17.395 | 19.088 | 20.017 | 18.192 | 0.495 | 0.352 | 0 | 0.54 | 0 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 2.347 | 3.513 | 1.433 | 1.566 | 2.396 | 1.473 | 1.273 | 0.646 | 0.977 | 0.306 | 0.143 | 0.618 | 0.183 | 0 | 0.252 | 0 |
Short Term Debt
| 0.048 | 0.034 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.05 | 4.1 | 4.1 | 0 | 4.1 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.193 | 0.436 | 0.403 | 0 | 0.343 | 0 |
Other Current Liabilities
| 1.507 | 2.11 | 2.289 | 1.259 | 0 | 0 | 0 | 0 | 0 | 0.009 | 0.202 | 1.31 | 1.31 | 0 | 0.575 | 0 |
Total Current Liabilities
| 3.902 | 5.657 | 3.722 | 2.826 | 2.396 | 1.473 | 1.273 | 0.646 | 0.977 | 0.365 | 0.202 | 6.464 | 5.996 | 0 | 5.27 | 0 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 1.043 | 1.059 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.147 | 0.127 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| -0 | -0 | 0 | 0 | 0 | 0 | 0.475 | 0.646 | 0 | 0.356 | 0 | 0.08 | 0.08 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 1.043 | 1.059 | 0 | 0 | 0 | 0 | 0.475 | 0.646 | 0 | 0.356 | 0 | 0.227 | 0.207 | 0 | 0 | 0 |
Total Liabilities
| 4.945 | 6.716 | 3.722 | 2.826 | 2.396 | 1.473 | 1.748 | 0.646 | 0.977 | 0.365 | 0.202 | 6.691 | 6.202 | 0 | 5.27 | 0 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.003 | 0.003 | 0.002 | 0.002 | 0.002 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings
| -63.063 | -58.67 | -53.411 | -48.322 | -44.041 | -40.465 | -37.985 | -34.185 | -32.65 | -31.088 | -29.756 | -7 | -6.597 | 0 | -5.372 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0.117 | 0.09 | 0.135 | 0.047 | 0.081 | 0.083 | 0.087 | 0.062 | 0.102 | 0.141 | 0.125 | 0.124 | 0.127 | -4.731 | 0.132 | -3.646 |
Other Total Stockholders Equity
| 86.835 | 86.493 | 69.68 | 68.047 | 57.186 | 52.152 | 51.057 | 50.871 | 50.657 | 50.598 | 47.619 | 0.68 | 0.618 | 0 | 0.509 | 0 |
Total Shareholders Equity
| 23.891 | 27.915 | 16.405 | 19.774 | 13.227 | 11.771 | 13.16 | 16.749 | 18.111 | 19.652 | 17.99 | -6.196 | -5.851 | -4.731 | -4.731 | -3.646 |
Total Equity
| 23.891 | 27.632 | 16.203 | 19.649 | 13.171 | 11.739 | 13.16 | 16.749 | 18.111 | 19.652 | 17.99 | -6.196 | -5.851 | -4.731 | -4.731 | -3.646 |
Total Liabilities & Shareholders Equity
| 28.836 | 34.348 | 19.925 | 22.475 | 15.566 | 13.211 | 14.908 | 17.395 | 19.088 | 20.017 | 18.192 | 0.495 | 0.352 | -4.731 | 0.54 | -3.646 |